[1] LLOYD-JONES D,ADAMS R J,BROWN T M,et al.Heart disease and stroke statistics-2010 update: a report from the american heart association[J].Circulation,2010,121(7): e46-e215.
[2] CARNEY R M,FREEDLAND K E.Depression in patients with coronary heart disease[J].Am J Med,2008,121(11): S20-S27.
[3] SCHERRER J F,CHRUSCIEL T,GARFIELD L D,et al.Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction[J].Br J Psychiatry,2012,200(2): 137-142.
[4] HUFFMAN J C,SMITH F A,BLAIS M A,et al.Pre-existing major depression predicts in-hospital cardiac complications after acute myocardial infarction[J].Psychosomatics,2008,49(4): 309-316.
[5] 胡大一.心血管疾病和精神心理障碍的综合管理——"双心医学"模式的探索[J].中国临床医生,2006,34(5): 2-3.
[6] WILLIAMS M S.Platelets and depression in cardiovascular disease: a brief review of the current literature[J].World J Psychiatry,2012,2(6): 114-123.
[7] SEREBRUANY V L,GLASSMAN A H,MALININ A I,et al.Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the sertraline antidepressant heart attack randomized trial(SADHART) platelet substudy[J].Circulation,2003,108(8): 939-944.
[8] GOODYER I M,HERBERT J,TAMPLIN A.Psychoendocrine antecedents of persistent first-episode major depression in adolescents: a community-based longitudinal enquiry[J].Psychol Med,2003,33(4): 601-610.
[9] SCHAEFER M,HORN M,SCHMIDT F,et al.Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-α[J].Brain Behav Immun,2004,18(6): 555-562.
[10] PARISSIS J T,ADAMOPOULOS S,RIGAS A,et al.Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression[J].Am J Cardio,2004,94(10): 1326-1328.
[11] GOLD P W,WONG M L,GOLDSTEIN D S,et al.Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia[J].Proc Natl Acad Sci USA,2005,102(23): 8303-8308.
[12] OTTE C,MARMAR C R,PIPKIN S S,et al.Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: the Heart and Soul Study[J].Biol Psychiatry,2004,56(4): 241-247.
[13] CARNEY R M,FREEDLADN K E.Depression and heart rate variability in patients with coronary heart disease[J].Cleve Clin J Med,2009,76(2): S13-S17.
[14] PIZZI C,MANZOLI L,MANCINI S,et al.Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability,markers of inflammation,and endothelial function[J].Eur Heart J,2008,29(9): 1110-1117.
[15] WANG Y,ZHAO X,O'NEIL A,et al.Altered cardiac autonomic nervous function in depression[J].BMC Psychiatry,2013,13(1): 187-193.
[16] 邓兆安,胡建.褪黑素与抑郁关系的研究进展[J].精神疾病与精神卫生,2013,13(6): 565-568.
[17] CARNEY R M,FREEDLADN K E,JAFFE A S.Altered circadian pattern of acute myocardial infarction in patients with depression[J].Coronary Artery Disease,1991,2(1): 61-65.
[18] SIMON N M,SMOLLER J W,MCNAMARA K L,et al.Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging[J].Biol Psychiatry,2006,60(5): 432-435.
[19] MCNAMARA R K,LIU Y.Reduced expression of fatty acid biosynthesis genes in the prefrontal cortex of patients with major depressive disorder[J].J Affect Disord,2011,129(1-3): 359-363.
[20] McCAFFERY J M,DUAN Q L,FRASURE-SMITH N,et al.Genetic predictors of depressive symptoms in cardiac patients[J].Am J Med Genet B Neuropsychiatr Genet,2009,150B(3): 381-388.
[21] KRONISH I M,RIECKMANN N,HALM E A,et al.Persistent depression affects adherence to secondary revention behaviors after acute coronary syndromes[J].J Gen Intern Med,2006,21(11): 1178-1183.
[22] BUNDE J,MARTIN R.Depression and prehospital delay in the context of myocardial infarction[J].Psychol Med,2006,68(1): 51-57.
[23] DRUSS B G,BRADFORD D W,ROSENHECK R A,et al.Mental disorders and use of cardiovascular procedures after myocardial infarction[J].JAMA,2000,283(4): 506-511.
[24] GEHI A,HAAS D,PIPKIN S,et al.Depression and medication adherence in outpatients with coronary heart disease: findings from the heart and soul study[J].Arch Intern Med,2005,165(21): 2508-2513.
[25] HO P M,SPERTUS J A,MASOUDI F A,et al.Impact of medication therapy discontinuation on mortality after myocardial infarction[J].Arch Intern Med,2006,166(17): 1842-1847.
[26] MAZZA M,LOTRIONTE M,BIONDI-ZOCAI G,et al.Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis[J].J Psychopharmacol,2010,24(12): 1785-1792.
[27] CUIJPERS P,GERAEDTS A S,van OPPEN P,et al.Interpersonal psychotherapy for depression: a Meta-analysis[J].Am J Psychiatry,2011,168(6): 581-592.
[28] NACI H,IOANNIDIS J P.Comparative effectiveness of exercise and drug interventions on mortality outcomes: Meta Epidemiological Study[J].BMJ,2013,347(10): f5577.
[29] TRIVEDI M H,GREER T L,CHURCH T S,et al.Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized,parallel dose comparison[J].J Clin Psychiatry,2011,72(5): 677-684.
[30] ELSAYED M,BANASR M,DURIC V,et al.Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression[J].Biol Psychiatry,2012,72(4): 258-265. |
